Chrysler
Summary
NHTSA campaign 23V382: Chrysler recalled for a safety defect. An unexpected decrease in brake performance increases the risk of a crash.
Details
Source
nhtsa
External ID
23V382
Action Date
2023-05-30
Status
Ongoing
Category
vehicle
Product Description
Chrysler (FCA US, LLC) is recalling certain 2017-2020 Alfa Romeo Giulia and 2018-2020 Alfa Romeo Stelvio vehicles equipped with carbon ceramic matrix brakes. During certain driving maneuvers, the brake system may exert an excessive clamp force that may fracture the rotor, decreasing the brake performance.
Company
Context & Analysis
Chrysler has 242 FDA actions in our database.
Frequently Asked Questions
How often does Chrysler have FDA actions?
Chrysler has 242 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle